Where The Wealth Is
Diversified remains the largest contributor to the wealth of India’s richest in 2024, accounting for 36.1% of total wealth.
Advertisement
pharma
September 2024
August 2024
July 2024
June 2024
Dr. Reddy’s shares hit record high! Pharma stock up 5% in 3 sessions
Shares of Dr. Reddy's Laboratories have risen 36% against its 52-week low of ₹5,212.10 touched on October 30, 2023.
Lupin shares touch 52-week high as Q1 profit surges 77%
Lupin deals in branded and generic formulations, active pharmaceutical ingredients (APIs), and biosimilars.
Sun Pharma Q1 profit surges 40% to ₹2,836 cr
The pharma company's revenue for the April-June quarter rose by 5.9% to ₹12,652.75 crore
Mankind Pharma Q1 results: Profit rises 10% to ₹543 cr; revenue up 12%
The revenue from domestic business grew 9% YoY to ₹2,634 cr in Q1 FY25, while exports rose 62% YoY to ₹259 cr
Akums Drugs raises ₹829 cr from anchor investor; check GMP, IPO details
Ahead of the opening of the IPO, shares of Akums Drugs were commanding a GMP of ₹205 apiece over the issue price of ₹646-679 per share in the unlisted market.
Akums Drugs to raise ₹1,857 cr at price band of ₹646-679 a share; IPO to open on July 30
The IPO of Akums Drugs and Pharmaceuticals is a combination of fresh equities worth ₹680 crore and OFS of 1.73 crore shares worth ₹1,177 crore.
Aurobindo Pharma announces share buyback worth ₹750 cr; stock drops 2%
The pharma company has fixed floor price for share buyback at ₹1,460 per share, a premium of 6.4% over Tuesday's closing price of ₹1,371.70 on the BSE.
Dr. Reddy's shares rise 3% on buying Haleon’s nicotine gum biz; here’s what brokerages say
The pharma major has agreed to acquire Haleon Plc’s Nicotinell and related portfolio outside of the U.S., for 500 million pounds.
Sun Pharma shares drop 2% on USFDA warning letter
The USFDA has issued a letter for violations of Current Good Manufacturing Practice (cGMP) regulations at Sun Pharma’s Dadra facility.
